机译:塞来昔布联合化疗和放疗治疗局部晚期食管癌患者的I / II期试验
Department of Haematology and Medical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Haematology and Medical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Haematology and Medical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Haematology and Medical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Haematology and Medical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Radiation Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Radiation Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Radiation Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Centre for Biostatistics and Clinical Trials Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Division of Surgical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Department of Haematology and Medical Oncology Peter MacCallum Cancer Centre Locked Bag 1 A’Beckett St Victoria 8006 Australia;
Celecoxib; Chemotherapy; Oesophageal cancer; Radiotherapy;
机译:塞来昔布联合化疗和放疗在局部晚期食道癌患者中进行的I / II期试验。
机译:在局部晚期肛门癌的治疗中,伴随放疗和化疗优于单纯放疗:欧洲癌症放疗和治疗研究与治疗组织III期随机试验的结果
机译:对于局部晚期非小细胞肺癌患者(IIIa / IIIb期),诱导化疗,同步化疗和确定性大剂量放疗:I / II期试验性试验。
机译:Neoadjuvant在直肠癌中治疗:我们总是需要放射治疗 - 或者我们是否可以更好地评估当地先进的直肠癌?
机译:晚期胃癌患者化学疗法的治疗模式和成本效益
机译:剂量升级的放疗与PET / CT的治疗计划与局部晚期(UT3 / T4)鳞状细胞癌的诱导和同时化疗联合食管:I / II期试验的成熟结果
机译:个性化适应性放射治疗与局部晚期非小细胞肺癌患者的化疗与标准放射治疗:多中心随机期III临床试验CRTOG1601